Kiwon lafiyaGani

Farfesa Skulachev: ido saukad. Ido saukad "Vizomitin" (saukad Skulachev) reviews, price, jagora

Lokaci bai tsaya har yanzu, kuma duk nazarin halittu rayuwa siffofin on Earth ne batun tsufa canje-canje. Kunno kai tsufa matakai sanin bayyanar rashin biyan bukata nasu kwayoyin da sauransu, abin da ya faru na motsi a lokacin m numfashi, dyspnea, gajiyayye hali da kuma tauye motsi. Bugu da ƙari kuma, hangen nesa tabarbarewa.Idan.

Akwai wani ra'ayi, wanda, ba zato ba tsammani, shi ne sosai na kowa da cewa tsufa tsari ba wani abu da dakatar, da kuma rage gudu kusan ba zai yiwu. Farfesa Skulachev, ido saukad da su ne da gaske mu'ujiza sakamako, bãyukansu da sauran ra'ayi.

Hakika, tsufa - ne na halitta tsari, amma saboda wasu dalilai da shi ba zai iya rage gudu? Tsufa ba tare da dalili. A cikin da'irar masana kimiyya da hannu a cikin tsufa tsari na jikin mutum, akwai wani karfi ra'ayi cewa a cikin DNA sarkar rubuta musamman shirin cewa shi ne alhakin da tsufa tsari a cikin jiki. Bayan kai a wasu shekaru, akwai wani kunnawa da shirin, wanda kyakkyawan take kaiwa zuwa makawa - mutuwa.

Mene ne m ga tsufa idanu

Take hakkin da matakai na gani ji ne daya daga cikin alamun tsufa. Babu, ba shakka, za ka iya saduwa da mutane tare da wata babbar jiha na lafiya, wanda shi ne isa ga wani aiki da cikakken fledged adawa dukan cututtuka na tsufa, amma idan wani mutum ba zato ba tsammani rasa hangen nesa, ko shi zai deteriorate da cika fuska, ko da irin wannan "gwarzo" wãyi wanzuwa ga wata tawaya.

Mafi yawan wa ido cututtuka ci gaba a kan lokaci sosai a hankali. Tare da shekaru, da lacrimal gland shine yake aiki kasa, kuma wannan entails a rage a samar da quality na hawaye. Yana zama m bayan kai shekaru 40 da haihuwa, amma zai iya faruwa da kuma bayan 30.

Kamar, abin da ke da wannan? Yana da na halitta da cewa tare da shekaru zama sirara m ido plyonochku ƙara faruwa corneal microtrauma da kuma lalacewa, kumburi cututtuka, da sauri eyestrain. A kara irin microchanges ne tushe ga ci gaban mafi barazanar cututtuka irin cataract, ta ƙara intraocular matsa lamba tare da ci gaban glaucoma, iya fara degenerative canje-canje na akan tantanin ido da kuma na gani jijiya daga m asarar hangen nesa. Amma kada ku ji tsõron cewa wadannan cututtuka na iya faruwa, da kuma duk a cikin wani jiffy. Su ci gaba ne jinkirin da hankali.

Wannan ya tura da cewa farfesa yanke shawarar kirkiro Skulachev ido saukad. Reviews to nema su sosai tabbatacce. A manya-manyan, idan ba mai girma, da yawan ophthalmic marasa lafiya samu damar sake tare da wata hujja-sa ido look at duniya ba tare da tiyata. Kuma godiya ga cewa ƙirƙira by Farfesa Skulachev ido saukad, farashin wanda yake fiye da mulkin demokra] iyya.

Antioxidants kamar mitochondrial

A Moscow Jami'ar Jihar. University tun shekarar 2005, ya fara wani bincike aikin a kan ci gaban da kwayoyi tsara don jinkirta da kunnawa da shirin da kuma rage gudu da tsufa. A karkashin shiryarwar V. P. Skulacheva, Academician na Rasha, Academy of Sciences, Masanin kimiyyar wanda for fiye da shekara arba'in tsunduma a gudanar da bincike na matakai faruwa a mitochondria, da aka kirkiro sabon nau'in aiki sinadaran - antioxidants mitochondrial irin.

Ta hanyar nazari bayan na farko da sabuwar dabara na da irin wannan sunadarai, masana kimiyya sun gano cewa mitochondrial antioxidants ragae, da kuma a wasu lokuta juyawa da matakai na ophthalmic cututtuka a dabbobi a cikin gwaji. mai yawa aiki a kan sabuwar dabara na sabon kwayoyi bisa mitochondrial antioxidants da aka yi a 'yan shekaru baya, da kuma Farfesa Skulachev ido saukad da aka gabatar a karkashin sunan "Vizomitin".

Bari mu dubi daya daga cikin alamun da tsufa ido - shekaru da alaka da tabarbarewa daga cikin lacrimal gland shine yake. Abin da ya faru tare da shekaru? Tare da shekaru akwai wani karu da yawa, kuma ingantattun halaye na lacrimal ruwa, saboda haka, ci gaban da ciwo na "bushe idanu". An bayyana da farko ji na rashin jin daɗi a cikin idanu, a ji na yashi ko kananan kasashen waje jiki, da kuma tare da wani hankali ci gaban da cutar iya fuskanci mafi tsanani sakamakon.

Lura da cewa maniyyi daga cataracts a halin yanzu zama a cikin Pharmaceutical kasuwar a manyan lambobin. Har ila yau manyan da adadin kwayoyi da nufin lura da symptomatic bayyananen a lokacin "bushe ido", amma kusan dukkan su (ko mafi yawan) ne a roba analogue na mutum hawaye ruwa. Su main hasara ne cewa haƙuri yana yin amfani da wadannan kwayoyi daga 10 zuwa 20-25 sau a rana, tun da amfani da kawai da nufin maido da al'ada da hawaye m abun ciki a cikin ido.

Laboratory da kuma na asibiti gwaje-gwaje

The latest drop "Vizomitin" bambanta fundamentally daga qa'ida ta aiki irin wannan kwayoyi amfani domin lura da bushe ido. Su ne sosai hanyar cutar, inganta aiki na lacrimal gland shine yake da tsayawa ta degenerative canje-canje. Bugu da ƙari, fesa droplets da irin wannan sakamako a matsayin droplets na cataract tushen wucin gadi hawaye.

Wannan shã'aninku - shi ne ba kawai wani ne msar tambayar sanarwa, amma a zahiri kafa hujja. Farfesa Skulachev ido saukad da karfi da gudanar da bincike a cikin dabbobi da gwajinsu da miyagun ƙwayoyi da aka gudanar a da yawa ido cibiyoyin: a sashen Ophthalmology (Rasha Jihar Medical University) da kuma a Research Institute of Eye Cututtuka Helmholtz.

A sakamakon samu a wadannan karatu da gwajinsu, sakamakon suna quite arfafa. Farfesa Skulachev, ido saukad, wanda aka ke ~ a karkashin sunan "Vizomitin", ya ce su ne yafi tasiri fiye da irin wannan kwayoyi amfani domin lura da kuma kawar da su da ãyõyin na ciwo na "bushe ido". Haka kuma, ya kamata a lura da cewa illa a lokacin jiyya da wadannan saukad da a marasa lafiya da aka kiyaye.

Bisa ga sakamakon da wadannan karatu, da miyagun ƙwayoyi da aka rajista, a Ma'aikatar Lafiya da kuma Social Development a watan Disamba 2011 a matsayin wajen keratoprotektornogo kira "Vizomitin", ko ido saukad Skulachev. Ina saya magani a yau? Tun da rani na shekara ta 2012, ya bayyana a kasar kiri cibiyar sadarwa Pharmacy.

Hakika, kamar wani sabon maganin da a baya aka sani aiki abu "Vizomitin" saki kawai da sayen magani. Zan iya saya ba tare da ido saukad da Skulachev? Ina saya su, idan ba da girke-girke? Kada koma ga dabaru, da kuma tuntuɓi mai halartar ophthalmologist. Vacation miyagun ƙwayoyi sayen magani ba lallai ba ne su koma zuwa shortcomings - shi sun fi mayar da kayyade ta niyya nufi, wanda, bi da bi, yakan haifar da mai kyau sakamako a kan aikace-aikacen.

A gaske musamman samu sanya da Farfesa Skulachev. Ido saukad, wanda sake dubawa kawai hadu kyau, haƙĩƙa, da banmamaki sakamako. Domin su aiwatar da asibiti karatu ya zama opticians ba kawai a Rasha amma kuma duk duniya. Wannan magani batun raba taro da kuma nazarinsa domin kawo bayanai zuwa kowane ophthalmologist.

Bari mu zauna a more daki-daki a "Vizomitin" shirye-shiryen. Umurnai na amfani iya ba mai yawa ban sha'awa bayani.

Description of shiri

Wannan yana nufin ne ma m, yiwu a canza launin da ɗan ko dan kadan opalescent ruwa. Plastohinonildetsiltrifenilfosfoniya aiki abu ne bromide, wanda a 1 ml na cikin shirye-shiryen ƙunshi 0,155 micrograms. Kamar yadda excipients amfani benzalkonium chloride, hypromellose, sodium chloride da sauransu. Wannan magani nasa ne da kungiyar keratoprotektornyh pharmacotherapeutic jamiái, kazalika da kungiyar na antioxidants.

Data a kan pharmacodynamics

Plastohinonildetsiltrifenilfosfoniya bromide fili ne wanda aka samu daga plastoquinone wanda ta hanyar haka ya kira linker sarkar hade tare da saura triphenylphosphine. Kamar yadda Dr Skulachev ce ido saukad (Farashin ga su saboda zumunta cheapness na kira na da wannan fili shi ne ba high) a nanomolar yawa iya exhibiting sosai high aiki antioxidant da high stimulating sakamako a kan slezoobrazovaniya matakai don kara jiki da kwanciyar hankali kafa ta hawaye fim da ma suna da wani sakamako a kan epitealizatsii tafiyar matakai.

pharmacokinetic data

Don kwanan wata, ya kamata a ce cewa da dama pharmacokinetic karatu sun ba da aka gudanar a cikin mutane. Tare da girmamawa ga pre-asibiti dabba karatu, da rarraba aiki abu droplets a cikin kwayoyin da aka lura kwanaki 2 bayan baka ko parenteral gwamnati. A gaban bromide plastohinonildetsiltrifenilfosfoniya aka rajista a cikin mafi girman yawa a koda nama da kuma hanta nama, zuciya bayan awa 1 bayan gwamnati. An lura cewa abu sosai da sauri hõre Lalacewar amfani da enzymes da kuma tabbatar da iya covalent shaidu da sunadarai.

Alamomi da kuma contraindications

Saukad Skulachev "Vizomitin" nada a cikin ciwo na "bushe ido", shekaru da alaka da canje-canje na lacrimal gland shine yake, kwamfuta ciwo. Kahu a kan gaskiyar cewa kimiyya da bincike a cikin effects da miyagun ƙwayoyi ne har yanzu gudana, an kuma bada shawarar ga cataract, glaucoma da hadaddun lura da wani cuta a cikin ophthalmology.

Kamar yadda Skulachev Vladimir nuna, ido saukad da aka contraindicated a hali na hypersensitivity da miyagun ƙwayoyi, kazalika da yara yan kasa da shekaru 18 da shekaru.

Aikace-aikace na ciki da kuma a lokacin shayarwa

Don kwanan wata, full-yi da ka, makafi, sarrafawa da karatu da miyagun ƙwayoyi a ciki mata, kazalika da aka za'ayi a shayarwa. A ra'ayi na wannan shã'aninku, shi ba da shawarar yin amfani da miyagun ƙwayoyi a lokacin gestation. Idan akwai dire bukatar saduwa a cikin lactation lokaci, nono-ciyar ya kamata a katse.

Hanyar aikace-aikace da kuma sashi

A miyagun ƙwayoyi ya kamata a shuka 1-2 saukad da cikin da conjunctival jakar kwai na haƙuri da ido sau uku a rana. Dangane da tsanani daga cututtuka da kuma mai tsanani daga cikin tsawon lokaci da warkewa Hakika na cutar za a iya kafa akayi daban-daban zalunta ophthalmologist.

Side effects da kuma yawan abin sama

Bisa ga bincike, kazalika da na asibiti da kuma awon gwaji da miyagun ƙwayoyi, illa da aka gano ba, amma zai iya zama wata alama ce ta rashin lafiyan halayen. Data yawan abin sama da Topical aikace-aikace na miyagun ƙwayoyi samuwa.

Drug interactions

Data ga miyagun ƙwayoyi interactions da sauran kwayoyi da kungiyoyin. Idan akwai bukatar domin na lokaci daya aikace-aikace "Vizomitina" da sauran ido saukad, ido instillation rata tsakanin kamata a kalla 5 da minti.

tsõratar

A gwajinsu da miyagun ƙwayoyi da sakamakon da aka samu, da cewa "Vizomitin" iya haddasa gajere masauki disturbances, bi da raguwa. Idan bayan gwamnati da miyagun ƙwayoyi ne lura da gani disturbances, kamata dena abin hawa ko iko sunadaran, kazalika da aiwatar da ayyukan da bukatar da hankali, har cikakken maida na gani acuity.

saki Form

Ido saukad da wani aiki sashi abun ciki na 0,155 ug / ml ake samar a musamman kwalabe na polyethylene 5 ml girma tare da stoppers - droppers da dunƙule hula. Da miyagun ƙwayoyi da aka saki kawai da sayen magani. Ka mai ido drop an zama dole a zazzabi na daga 2 zuwa 8 0 C.

Inda saya da miyagun ƙwayoyi

Buy saukad "Vizomitin" wanda farashin yau ba mai girma, idan ka ba da labari da shi a da ana tsammanin sakamako, yana yiwuwa a kusan kowane kantin magunguna Rasha. The talakawan kudin a Rasha Federation droplets ne game da 500 rubles. The sakamako daga cikin miyagun ƙwayoyi kawai imbin. A babbar yawan mutane sun iya share da haske ta hanyar wannan yana nufin. Kamar yadda aka nuna da Farfesa Skulachev, ido saukad, farashin wanda yake samuwa ga kowa da kowa zai yi wani tasiri warkewa sakamako ne wadanda suka sha wahala daga ido cututtuka.

Babu shakka cewa bayan wani lokaci, bincike jami'o'i kammala karatu cikakken sikelin-binciken da ido saukad "Vizomitin" sa'an nan da high yiwuwa za a sabuwar dama ga yin amfani da mitochondrial antioxidants ba kawai a cikin asibiti yi na ophthalmology, amma kuma a cikin sauran rassan magani.

Sharhi kan shirye-shiryen

Wurare da dama a shedu da mutanen da suka yi amfani da ido saukad "Vizomitin" bisa laákari da mataki. Marasa lafiya suna murna da cewa shirye-shiryen da ba ya bukatar da m instillation, kuma tare da shafe tsawon amfani, da kuma bai wa mita na ta yin amfani da za a iya rage zuwa sau daya a rana. A cewar masu amfani da, ido matsaloli sosai a warware. Su gushe zuwa blush, kasa gaji, kumburi faruwa. Duk wani illa, marasa lafiya da aka ba lura.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 ha.birmiss.com. Theme powered by WordPress.